• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Rs. 100 crore fund from PM CARES Fund for COVID-19 vaccine to PSA of PMO : Progress till now?

Rs. 100 crore fund from PM CARES Fund for COVID-19 vaccine to PSA of PMO : Progress till now?

0
By Biotech Express on July 20, 2020 Articles, Articles- Guestorials, SARS- CoV2 & COVID-19 Updates

by Sumit Kumar

Dr K Vijayraghavan (PSA to PMO) was visible on national TVs to much extent until the announcement of 12 or 13 May, when he got 100 crore Rs. for the development of vaccine against COVID-19. Since then it is very difficult to find him on any national news platform to see what developments he is directing toward the assigned tasks of vaccine development, communicated Sumit Kumar to Biotech Express. (https://www.livemint.com/news/india/pm-fund-allocates-rs-3-100-cr-to-boost-fight-against-covid-19-11589391319927.html)

As per the office’s press release the following tasks were facilitated but how they were unique and useful we will check them later. Here is the complete List of initiatives by the Office of the Principal Scientific Adviser to the Government of India, on COVID-19:

The office of the PSA has played coordinating role for government ministries/departments, scientific institutions, academia and enterprises to accelerate decisions on dealing with research and innovation based actions to meet the COVID-19 challenges.

  • It has enabled ICMR to issue the required notification allowing institutions under DST, DBT, CSIR, DAE, DRDO and Indian Institute of Science (IISc) to self-assess and prepare their BSL labs for research and testing of corona virus.
  • The O/o PSA has been instrumental in the launch and outreach of the AarogyaSetu App.
  • The O/o PSA has issued a detailed manual on homemade masks for curbing the spread of Coronavirus.
  • The O/o PSA issued illustrative guidelines with precautions and measures for controlling the spread of COVID-19 in densely populated areas on April 13, 2020.
  • The Office of the PSA has converged efforts across various government departments and programme to identify innovations that can tackle COVID-19 challenges.
  • The O/o PSA worked with the Ministry of Corporate Affairs for issuing an enabling OM for the use of CSR funds for research and innovation projects for providing solutions to meet the COVID-19 challenges.
  • A “Science & Technology core team” has been set up in the office of the Principal Scientific Advisor to crowdsource ideas and solutions from experts, companies, academia and citizens to tackle the spread of the Covid-19 virus in the country.

Source: http://psa.gov.in/sites/default/files/pdf/PSA_Office_Initiatives_COVID-19.pdf

It is nowhere understood from the above points that why the scientist sitting on topmost scientific position of country is not talking about science and its development. For example, in this PR, it is not discussed what initiatives he has taken to identify vaccine candidate, what facilities they are using and when the vaccine will probably come.

Earlier a article written in Biotech Express show how different govt. department formed their own groups of expertise and then start taking their own initiatives. Inspite of enormous collaboration and support from govt. departments, office of PSA to PM office has not shown any sign of development w.r.t vaccine development.
(http://www.biotechexpressmag.com/editorial-why-indian-bioscience-response-is-not-enough-to-curb-global-covid19-biological-pandemic-what-are-we-missing/)

The most demanding thing in this world now is vaccine against novel CoV, many countries have launched their candidates but thanks to the politics of Indian sciences we have not registered even a single candidate vaccine on global platforms.

Recently, ICMR launched COVAXIN but soon was surrounded by controversies on risk criteria and timeline. Though ICMR was criticized, we cannot ignore two facts, that such announcement were also made by other regulatory organizations in past few months and several drugs were approved for emergency use authorization and secondly, at least ICMR either independently or in collaboration with industry player(s) has come up with a candidate.

Coming back to PSA, I am curious to know that how he is planning to use these precious 100 crore of public donation that he received for vaccine development and what are the activities done till now in this regard. As we have seen no innovation from PSA office, is it correct to ask whether our 100 crore will be utilized or will be wasted.

To know more about vaccine development, we communicated questions posed by Sumit Kumar to Dr Vijayraghavan but despite several attempts we could not get any response from PSA to PMO, Dr K Vijayraghavan.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Researchers who jumped into the field from distant disciplines published lower impact work, study finds

Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.